AI drug researchAnthropic acquires Mithril Medicine to expand AI-assisted drug research
The acquisition brings early muscular-dystrophy research into Anthropic, with mouse results and a conditional late-2028 clinical-trial goal.

New models, clear comparisons and choosing a model for the task.
AI drug researchThe acquisition brings early muscular-dystrophy research into Anthropic, with mouse results and a conditional late-2028 clinical-trial goal.
IPO cash positionThe filing reports $112.4 billion in cash and equivalents at June 30, while the proposed offering remains unfinished.
Choose the next stepLast Week in AI explains an alternative to generating a long answer for every small decision.
Learning to improveLast Week in AI explains two papers about how AI systems could improve the way they learn and explore.
Chat gets a faceLast Week in AI discusses Google’s real-time avatars for enterprise conversations.
Open weightsMuse Spark Open combines multimodal input with downloadable weights and demanding self-hosting requirements.
Connected voice toolsMistral combines speech models with a developer SDK for agents that can listen, respond and use software tools.
More for lessLast Week in AI discusses two model launches focused on faster work and lower costs.

What mathematical manuscripts and TasteVal actually establish—and why benchmark gains are not complete research automation.
AI on deviceLiquid AI has introduced the compact LFM3 family for text, vision and audio tasks.
Learn. Keep.Google Research describes SLEEP, a method intended to help models learn new information while retaining earlier knowledge.
Open, but bigMatt Wolfe examines Kimi K3.1 Pro’s reported benchmarks and the gap between downloadable weights and practical local deployment.